Article Details

BridGene BioSciences Develops Chemoproteomic Platform for Drug, Target Discovery

Retrieved on: 2021-10-19 22:07:05

Tags for this article:

Click the tags to see associated articles and topics

BridGene BioSciences Develops Chemoproteomic Platform for Drug, Target Discovery. View article details on hiswai:

Excerpt

... mechanisms of debilitating neurological disorders," Ceri Davies, head of Takeda's Neuroscience Drug Discovery Unit, said in a statement.

Article found on: www.genomeweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up